Schedule 13G ownership disclosure

NOVELION THERAPEUTICS, INC.

Security class unavailable · CUSIP: 67001K202

Event date: 2019-05-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
946,842
Percent of class
4.9700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-19-002359
Form type
SC 13G/A
Filer
HIGHBRIDGE CAPITAL MANAGEMENT LLC
CIK
CIK 919185
Filed
May 15, 2019
Reporting period
May 15, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub